Chr. Hansen and Lonza’s joint venture, BacThera, receives anti-trust approvals to start contract manufacturing of LBPs
Chr. Hansen Holding A/S, a leading global bioscience company, and Lonza AG, a leading pharma contract manufacturing company, announce that they have received the relevant approvals from anti-trust regulators needed to establish the 50/50 joint […]